Journal of Clinical Anesthesia
Volume 21, Issue 8 , Pages 555-561 , December 2009

Effects of landiolol on QT interval and QT dispersion during induction of anesthesia using computerized measurement

  • Mizue Kaneko, MD (Staff Anesthesiologist)

      Affiliations

    • Department of Anesthesiology, Dokkyo Medical University, School of Medicine, Tochigi 321-0293, Japan
    • ,
  • Shigeki Yamaguchi, MD, PhD (Associate Professor)

      Affiliations

    • Department of Anesthesiology, Dokkyo Medical University, School of Medicine, Tochigi 321-0293, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 282 86 1111; fax: +81 282 86 0478.
    • ,
  • Shinsuke Hamaguchi, MD, PhD (Associate Professor)

      Affiliations

    • Department of Anesthesiology, Dokkyo Medical University, School of Medicine, Tochigi 321-0293, Japan
    • ,
  • Hirotoshi Egawa, MD, PhD (Lecturer)

      Affiliations

    • Department of Anesthesiology, Dokkyo Medical University, School of Medicine, Tochigi 321-0293, Japan
    • ,
  • Koichi Fujii, MD, PhD (Staff Anesthesiologist)

      Affiliations

    • Department of Anesthesiology, Dokkyo Medical University, School of Medicine, Tochigi 321-0293, Japan
    • ,
  • Kazuyoshi Ishikawa, MD (Staff Anesthesiologist)

      Affiliations

    • Department of Anesthesiology, Dokkyo Medical University, School of Medicine, Tochigi 321-0293, Japan
    • ,
  • Toshimitsu Kitajima, MD, PhD (Professor)

      Affiliations

    • Department of Anesthesiology, Dokkyo Medical University, School of Medicine, Tochigi 321-0293, Japan
    • ,
  • Junichi Minami, MD, PhD (Lecturer)

      Affiliations

    • Department of Hypertension and Cardiorenal Medicine, Dokkyo Medical University, School of Medicine, Tochigi 321-0293, Japan

Received 30 April 2008 ,Revised 26 December 2008 ,Accepted 30 December 2008.

References 

  1. Yamazaki A, Kinoshita H, Shimogai M, et al. Landiolol attenuates tachycardia in response to endotracheal intubation without affecting blood pressure. Can J Anaesth. 2005;52:254–257
  2. Goyagi T, Tanaka M, Nishikawa T. Landiolol attenuates the cardiovascular response to tracheal intubation. J Anesth. 2005;19:282–286
  3. Tan PH, Yang LC, Shih HC, Lin CR, Lan KC, Chen CS. Combined use of esmolol and nicardipine to blunt the haemodynamic changes following laryngoscopy and tracheal intubation. Anaesthesia. 2002;57:1207–1212
  4. Figueredo E, Garcia-Fuentes EM. Assessment of the efficacy of esmolol on the haemodynamic changes induced by laryngoscopy and tracheal intubation: a meta-analysis. Acta Anaesthesiol Scand. 2001;45:1011–1022
  5. Maguire A, Thompson JP, Guest C, Sadler PJ, Strupish JW, West KJ. Comparison of the effects of intravenous alfentanil and esmolol on the cardiovascular response to double-lumen endobronchial intubation. Anaesthesia. 2001;56:319–325
  6. Atlee JL, Dhamee MS, Olund TL, George V. The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation. Anesth Analg. 2000;90:280–285
  7. Chung KS, Sinatra RS, Chung JH. The effect of an intermediate dose of labetalol on heart rate and blood pressure responses to laryngoscopy and intubation. J Clin Anesth. 1992;4:11–15
  8. Oda Y, Nishikawa K, Hase I, Asada A. The short-acting β1-adrenoceptor antagonists esmolol and landiolol suppress the bispectal index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg. 2005;100:733–737
  9. Yoshida Y, Hongo T, Sakamoto A, Ogawa R. Successful management of tachycardiac atrial fibrillation in a septic patient with landiolol. Anesth Analg. 2005;100:294
  10. Mayahara T, Goto M, Sato M, et al. Conversion of atrial fibrillation to sinus rhythm during landiolol infusion. J Anesth. 2004;18:304–306
  11. Ogata J, Yokoyama T, Okamoto T, Minami K. Managing a tachyarrthmia in a patient with pheochromocytoma with landiolol, a novel ultrashort-acting beta-adrenergic blocker. Anesth Analg. 2003;97:294–295
  12. Ogata J, Okamoto T, Minami K. Landiolol for the treatment of tachyarrhythmia associated with atrial fibrillation. Can J Anaesth. 2003;50:753
  13. Murakami M, Furuie H, Matsuguma K, Wanibuchi A, Kikawa S, Irie S. Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting beta 1-selective blocker, in a dose escalation regimen in healthy male volunteers. Drug Metab Pharmacokinet. 2005;20:337–344
  14. Day CP, McComb JM, Campbell RW. An indication of arrhythmic risk in patients with long QT intervals. Br Heart J. 1990;63:342–344
  15. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam study. Circulation. 1998;97:467–472
  16. Dabrowski A, Kramarz E, Piotrowicz R. Dispersion of QT interval following ventricular premature beats and mortality after myocardial infarction. Cardiology. 1999;91:75–80
  17. Okin PM, Devereux RB, Howard BV, Fabsitz RR, Lee ET, Welty TK. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians. The strong heart study. Circulation. 2000;101:61–66
  18. Zaidi M, Roberts A, Fesler R, Derwael C, Brohet C. Dispersion of ventricular repolarization: a marker of ventricular arrhythmias in patients with previous myocardial infarction. Heart. 1997;78:371–375
  19. Lee KW, Okin PM, Kligfield P, Stein KM, Lerman BB. Precordial QT dispersion and inducible ventricular tachycardia. Am Heart J. 1997;134:1005–1013
  20. Zareba W, Moss AJ, Le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol. 1994;74:550–553
  21. McLaughlin NB, Campbell RW, Murray A. Accuracy of four automatic QT measurement techniques in cardiac patients and healthy subjects. Heart. 1996;76:422–426
  22. Xue Q, Reddy S. Algorithms for computerized QT analysis. J Electrocardiol. 1998;30 Suppl:181–186
  23. Fisch C. Electrocardiography. In:  Braunwald E editors. Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia: W.B. Saunders Company; 1997;p. 114
  24. Kortis JB, Rosen RC. Central nervous system effects of β-adrenergic-blocking drugs: the role of ancillary properties. Circulation. 1986;75:204–212
  25. Menigaux C, Guignard B, Adam F, Sessler DI, Joly V, Chauvin M. Esmolol prevents movement and attenuates the BIS response to orotracheal intubation. Br J Anaesth. 2002;89:857–862
  26. Tanskanen PE, Kyttä JV, Randell TT. QT interval and QT dispersion during the induction of anaesthesia in patients with subarachnoid haemorrhage: a comparison of thiopental and propofol. Eur J Anaesthesiol. 2002;19:749–754
  27. Korpinen R, Saarnivaara L, Siren K. QT interval of the ECG, heart rate and arterial pressure during anaesthetic induction: comparative effects of alfentanil and esmolol. Acta Anaesthesiol Scand. 1995;39:809–813
  28. Chang DJ, Kweon TD, Nam SB, et al. Effects of fentanyl pretreatment on the QTc interval during propofol induction. Anaesthesia. 2008;63:1056–1060
  29. Lindgren L, Rautiainen P, Klemola UM, Saarnivaara L. Haemodynamic responses and prolongation of QT interval of ECG after suxamethonium-facilitated intubation during anaesthetic induction in children: a dose-related attenuation by alfentanil. Acta Anaesthesiol Scand. 1991;35:355–358
  30. Kweon TD, Nam SB, Chang CH, et al. The effect of bolus administration of remifentanil on QTc interval during induction of sevoflurane anaesthesia. Anaesthesia. 2008;63:347–351
  31. Kleinsasser A, Kuenszberg E, Loeckinger A, et al. Sevoflurane, but not propofol, significantly prolongs the Q-T interval. Anesth Analg. 2000;90:25–27
  32. Güler N, Bilge M, Eryonucu B, Kati I, Demirel CB. The effects of halothane and sevoflurane on QT dispersion. Acta Cardiol. 1999;54:311–315
  33. Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Clin Pharmacol Ther. 1983;34:427–434
  34. Iguchi S, Iwamura H, Nishizaki M, et al. Development of highly cardioselective ultra short-acting β-blocker, ONO-1101. Chem Pharm Bull. 1992;40:1462–1469
  35. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting β-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth. 2001;48:985–989
  36. Goto K, Shingu C, Miyamoto S, Miyakawa H, Noguchi T. The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. J Clin Anesth. 2007;19:523–529
  37. Randell T, Tanskanen P, Scheinin M, Kytta J, Ohman J, Lindgren L. QT dispersion after subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1999;11:163–166
  38. Aytemir K, Aksoyek S, Ozer N, Gurlek A, Ota A. QT dispersion and autonomic nervous system function in patients with type 1 diabetes. Int J Cardiol. 1998;65:45–50
  39. Shimabukuro M, Chibana T, Yoshida H, Nagamine F, Komiya I, Takasu N. Increased QT dispersion and cardiac adrenergic dysinnervation in diabetic patients with autonomic neuropathy. Am J Cardiol. 1996;78:1057–1059
  40. Atarashi H, Kuruma A, Yashima M, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting β-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther. 2000;68:143–150

PII: S0952-8180(09)00265-7

doi: 10.1016/j.jclinane.2008.12.027

Journal of Clinical Anesthesia
Volume 21, Issue 8 , Pages 555-561 , December 2009

Article Tools

* Image Usage & Resolution